Elite Pharmaceuticals, Inc. Stock Other OTC
Equities
ELTP
US28659T2006
Pharmaceuticals
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
1st Jan change | Capi. | |
---|---|---|
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+7.98% | 13.02B | |
+6.28% | 13.53B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |